Mindesta Inc. has closed on its acquisition of CTT Pharmaceuticals Inc. In connection with the acquisition of CTT Pharma, Gregory Bowes tendered his resignation as company's sole officer and director. Dr. Pankaj Modi and Dean Hanisch were appointed officers and directors of Mindesta and Dr. Allen Greenspoon was appointed a director. Dr. Pankaj Modi, serves as the company's Chief Executive Officer and as a Director.

Dr. Modi received his M.D. in internal medicine (diabetology) from the Instituto de Endocrinologia Metabolismo y Reproduction, SA/University of Florida and completed a post-doctoral fellowship in neuroscience at McMaster University in Hamilton, Canada. Dean Hanisch, serves as the company's President and as a Director. Mr. Hanisch has over 15 years experience in business and finance and has worked for and served as a consultant to several public companies.

Since October 2011 he has worked for Steenberg Financial as a consultant for the company's North American brokerage services. Dr. Allen Greenspoon, serves as a Director. Dr. Greenspoon has been a practicing physician specializing in obstetrics and occupational health for over 25 years working in Hamilton, Ontario.

He has conducted multiple clinical research studies related to diabetes, lipids (cholesterol) management, dermatology, obesity, oncology related research and cardiovascular diseases.